Healthcare >> CEO Interviews >> February 18, 2002

William Gerber – Epoch Biosciences Inc (ebio)

DR. WILLIAM G. GERBER has served as Chief Executive Officer of Epoch Biosciences, Inc., since September 1999. From April 1998 until July 1999, Dr. Gerber served as President and Chief Executive Officer of diaDexus LLC, a joint venture established by Incyte Pharmaceuticals and SmithKline Beecham to apply genomic information and technologies to the discovery of novel diagnostic products. Dr. Gerber served as Vice President and Chief Operating Officer of Onyx Pharmaceuticals, a biotechnology firm involved in the discovery of novel cancer therapeutics, from June 1995 until April 1998 and as President of Chiron Diagnostics from December 1991 until June 1995. Previously, he was Senior Vice President and General Manager of the PCR Division with Cetus Corporation. Dr. Gerber also has medical practice and managerial experience in emergency medicine and founded an urgent care center management company. He served on and was President of the Board of Medical Quality Assurance, State of California. He received his MD and BS from the University of California, San Francisco Medical Center after attending Dartmouth College. Dr. Gerber is also on the Board of Directors of Sangamo BioSciences, Inc. Profile
TWST: Could we start out with a brief overview of the history and

evolution of Epoch Biosciences, Inc.?

Dr. Gerber: Epoch was started as a company called Microprobe back in the